scholarly journals The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study

2009 ◽  
Vol 32 (4) ◽  
pp. 289-298 ◽  
Author(s):  
Hiroyuki Noda ◽  
◽  
Hiroyasu Iso ◽  
Isao Saito ◽  
Masamitsu Konishi ◽  
...  
Keyword(s):  
Public Health ◽  
Metabolic Syndrome ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Health Center ◽  
Ischemic Heart ◽  
Public Health Center ◽  
The Metabolic Syndrome ◽  
The Impact

Modification of the NCEP ATP III definitions of the metabolic syndrome for use in Asians identifies individuals at risk of ischemic heart disease

2006 ◽  
Vol 186 (2) ◽  
pp. 367-373 ◽  
Author(s):  
Derrick Heng ◽  
Stefan Ma ◽  
Jeannette J.M. Lee ◽  
Bee Choo Tai ◽  
Koon Hou Mak ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
At Risk ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Ischemic Heart ◽  
The Metabolic Syndrome

scholarly journals Comparison of four definitions of the metabolic syndrome and odds of ischemic heart disease in the Lithuanian urban population

2011 ◽  
Vol 57 (3) ◽  
pp. 543-550 ◽  
Author(s):  
Dalia Ieva Luksiene ◽  
Migle Baceviciene ◽  
Abdonas Tamosiunas ◽  
Regina Reklaitiene ◽  
Ricardas Radisauskas
Keyword(s):  
Metabolic Syndrome ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Urban Population ◽  
Ischemic Heart ◽  
The Metabolic Syndrome

The metabolic syndrome as factor of additional cardio vascular risk under ischemic heart disease

2016 ◽  
Vol 22 (3) ◽  
pp. 120-124
Author(s):  
Aleksandr V. Dontsov
Keyword(s):  
Metabolic Syndrome ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
Total Cholesterol ◽  
Ischemic Heart ◽  
High Density Lipoproteins ◽  
The Metabolic Syndrome ◽  
Total Antioxidant ◽  
Cardio Vascular ◽  
Necrosis Factor

The sampling of 331 patients with ischemic heart disease was included in the study to evaluate biochemical, immunologic indicators of blood, affective condition. The analysis of blood serum of patients with ischemic heart disease revealed presence of increased levels of total cholesterol, triglycerides, leptin, insulin, HOMA-IR index, total oxidizing ability of blood, oxidized low-density lipoproteins, proinflammatory cytokines interleukins-1, interleukins-6, tumor necrosis factor, adrenocorticotrophic hormone, cortisol, lowered content of total cholesterol high-density lipoproteins, total antioxidant activity of blood, superoxiddismutase. Also, increased level of depression was established, especially expressed in case of presence of concomitant metabolic syndrome.

scholarly journals Prevalence of the metabolic syndrome diagnosed using three different definitions and risk of ischemic heart disease among Kaunas adult population

Medicina ◽  
2010 ◽  
Vol 46 (1) ◽  
pp. 61 ◽  
Author(s):  
Dalia Lukšienė ◽  
Miglė Bacevičienė ◽  
Abdonas Tamošiūnas ◽  
Liucija Černiauskienė ◽  
Lilija Margevičienė ◽  
...  
Keyword(s):  
Metabolic Syndrome ◽  
Heart Disease ◽  
Ischemic Heart Disease ◽  
International Diabetes Federation ◽  
Ischemic Heart ◽  
Adult Treatment ◽  
Adult Treatment Panel ◽  
International Diabetes Federation Definition ◽  
The Metabolic Syndrome ◽  
The World

The aim of this study was to compare the prevalence of the metabolic syndrome diagnosed using three different definitions and to evaluate its associations with ischemic heart disease in Kaunas adult population. Material and methods. Data of preventive screening carried out in Kaunas in 2001–2002 according to the MONICA study protocol were used for analysis; a total of 1336 persons aged 35–64 years (603 men and 733 women) were recruited. The metabolic syndrome was defined by the World Health Organization, Adult Treatment Panel III, and International Diabetes Federation definitions. Ischemic heart disease was diagnosed based on the following criteria: a documented history of myocardial infarction, angina pectoris, or ischemic changes on electrocardiogram. Results. The metabolic syndrome was identified for 11.3% of men and for 9.4% of women using the World Health Organization definition, for 19.4% of men and for 26.3% of women using the Adult Treatment Panel III definition, and for 30.0% of men and for 37.7% of women using the International Diabetes Federation definition. In male and female groups, the prevalence of the metabolic syndrome (irrespective of definition) significantly increased with age (P<0.05). After adjusting for age, men diagnosed with the metabolic syndrome using the International Diabetes Federation definition (OR=2.30; P=0.001) and Adult Treatment Panel III definition (OR=1.97; P=0.01) and women diagnosed with metabolic syndrome using the International Diabetes Federation definition (OR=1.50; P=0.039) had a significantly higher risk of having ischemic heart disease as compared with those without the metabolic syndrome by the same definitions. The metabolic syndrome diagnosed using the World Health Organization definition was not associated with a significant risk of ischemic heart disease in men and women. Conclusion. In Kaunas population aged 35–64 years, the highest prevalence of the metabolic syndrome was determined according to the International Diabetes Federation definition. Usage of the International Diabetes Federation and the Adult Treatment Panel III definitions in establishing diagnosis of the metabolic syndrome provides more opportunities to identify subjects with ischemic heart disease.

Sign in / Sign up

Export Citation Format

Share Document